viernes, 29 de julio de 2022

General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products Guidance for Industry | FDA

General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products Guidance for Industry | FDA

No hay comentarios: